US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Atossa Genetics

0.8511

+0.02062.48%

Post-market: 0.85190.0008+0.09%19:11 EDT

Volume:592.49K

Turnover:498.20K

Market Cap:109.94M

PE:-4.10

High:0.8565

Open:0.8300

Low:0.8104

Close:0.8305

Loading ...

Overview Company News Filings

Ascendiant Reaffirms Their Buy Rating on Atossa Therapeutics (ATOS)

Atossa Therapeutics initiated with a Buy at Craig-Hallum

Atossa Therapeutics Inc. to Present at Jefferies Global Healthcare Conference

Steven C. Quay, President & CEO, Reports Acquisition of Common Shares of Atossa Therapeutics Inc

Atossa Therapeutics Reports Promising Results from I-SPY 2 Trial Evaluating Low-Dose (Z)-Endoxifen in Breast Cancer Treatment

Atossa Therapeutics: Well‑Tolerated Safety Profile - Adverse Events Were Predominantly Grade 1

THOMSON REUTERS

Atossa Therapeutics: Announces Full Results From I‑Spy 2 Endocrine‑Optimization Sub‑Study Evaluating Low‑Dose (Z)‑Endoxifen

THOMSON REUTERS

Atossa Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary

Atossa Therapeutics Q1 EPS $(0.05) Beats $(0.06) Estimate

Atossa Therapeutics Reports No Revenue and Increased Operating Expenses in Q1 2025 Results

Atossa Therapeutics Q1 Operating Expenses USD 7.414 Million

THOMSON REUTERS

Atossa Therapeutics Inc expected to post a loss of 6 cents a share - Earnings Preview

Atossa Therapeutics and Ainos Interviews Aired on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

ACCESS Newswire

Atossa Therapeutics Gets US Patent Covering (Z)-endoxifen Breast Cancer Treatment

MT Newswires Live

Atossa Therapeutics Proposes Potentially Groundbreaking Study Aimed at Reducing Interval Breast Cancer in High-Risk Women at AACR 2025

Atossa Therapeutics announces issuance of U.S. patent

Atossa Therapeutics Announces Issuance of U.S. Patent No. 12,275,684, Further Strengthening (Z)-endoxifen Portfolio

Atossa Therapeutics Is Maintained at Buy by Ascendiant Capital

Nona Biosciences and Atossa Therapeutics Partner to Discover Next-Generation Antibody Therapies for Breast Cancer

BRIEF-Atossa Therapeutics says Intas Pharmaceuticals Filed Petition For Post Grant Review Against Co- SEC Filing

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/ATOS/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ATOS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ATOS\",,,,,undefined,":{"symbol":"ATOS","market":"US","secType":"STK","nameCN":"Atossa Genetics","latestPrice":0.8511,"timestamp":1750104000000,"preClose":0.8305,"halted":0,"volume":592491,"hourTrading":{"tag":"盘后","latestPrice":0.8519,"preClose":0.8511,"latestTime":"19:11 EDT","volume":6616,"amount":5617.1059,"timestamp":1750115489541},"delay":0,"floatShares":129098495,"shares":129170004,"eps":-0.207724,"marketStatus":"Not Yet Opened","change":0.0206,"latestTime":"06-16 16:00:00 EDT","open":0.83,"high":0.8565,"low":0.8104,"amount":498196.70909009996,"amplitude":0.055509,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.207724,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1750147200000},"marketStatusCode":0,"adr":0,"adrRate":0,"listingDate":1352350800000,"exchange":"NASDAQ","adjPreClose":0.8305,"preHourTrading":{"tag":"盘前","latestPrice":0.8303,"preClose":0.8305,"latestTime":"09:26 EDT","volume":6433,"amount":5477.1166702,"timestamp":1750080413934},"postHourTrading":{"tag":"盘后","latestPrice":0.8519,"preClose":0.8511,"latestTime":"19:11 EDT","volume":6616,"amount":5617.1059,"timestamp":1750115489541},"volumeRatio":0.917346,"impliedVol":0.9953,"impliedVolPercentile":0.396},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ATOS\",,,,,undefined,":{"symbol":"ATOS","floatShares":129098495,"roa":"-21.67%","roe":"-34.87%","lyrEps":-0.202639,"volumeRatio":0.917346,"shares":129170004,"dividePrice":0,"high":0.8565,"amplitude":0.055509,"preClose":0.8305,"low":0.8104,"week52Low":0.5526,"pbRate":"1.68","week52High":1.66,"institutionHeld":0,"latestPrice":0.8511,"eps":-0.207724,"divideRate":0,"volume":592491,"delay":0,"ttmEps":-0.207724,"open":0.83,"prevYearClose":0.9441,"prevWeekClose":0.8305,"prevMonthClose":0.7771,"prevQuarterClose":0.6729,"fiveDayClose":0.9141,"twentyDayClose":0.9701,"sixtyDayClose":0.7155},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ATOS\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2541287862","title":"Ascendiant Reaffirms Their Buy Rating on Atossa Therapeutics (ATOS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2541287862","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541287862?lang=en_us&edition=fundamental","pubTime":"2025-06-07 01:25","pubTimestamp":1749230716,"startTime":"0","endTime":"0","summary":"In a report released today, Edward Woo from Ascendiant maintained a Buy rating on Atossa Therapeutics (ATOS – Research Report), with a price target...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/ascendiant-reaffirms-their-buy-rating-on-atossa-therapeutics-atos-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/ascendiant-reaffirms-their-buy-rating-on-atossa-therapeutics-atos-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","ATOS"],"gpt_icon":0},{"id":"2541221830","title":"Atossa Therapeutics initiated with a Buy at Craig-Hallum","url":"https://stock-news.laohu8.com/highlight/detail?id=2541221830","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541221830?lang=en_us&edition=fundamental","pubTime":"2025-06-05 19:15","pubTimestamp":1749122125,"startTime":"0","endTime":"0","summary":"Craig-Hallum initiated coverage of Atossa Therapeutics (ATOS) with a Buy rating and $4 price target Published first on TheFly – the ultimate source...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/atossa-therapeutics-initiated-with-a-buy-at-craig-hallum-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/atossa-therapeutics-initiated-with-a-buy-at-craig-hallum-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ATOS","BK4007","BK4539","LENZ","BK4139"],"gpt_icon":0},{"id":"2540798086","title":"Atossa Therapeutics Inc. to Present at Jefferies Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2540798086","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540798086?lang=en_us&edition=fundamental","pubTime":"2025-06-02 20:45","pubTimestamp":1748868317,"startTime":"0","endTime":"0","summary":"Atossa Therapeutics Inc., a clinical-stage biopharmaceutical company focused on developing innovative medicines for breast cancer, announced that its President and CEO, Dr. Steven Quay, will present at the Jefferies Global Healthcare Conference. The presentation is scheduled for Thursday, June 5, 2025, at 7:35 a.m. Eastern Time. A live webcast of the presentation will be available on Atossa's website.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Atossa Therapeutics Inc. published the original content used to generate this news brief via PR Newswire  on June 02, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250602:nNDL2l5YR8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ATOS"],"gpt_icon":0},{"id":"2537397890","title":"Steven C. Quay, President & CEO, Reports Acquisition of Common Shares of Atossa Therapeutics Inc","url":"https://stock-news.laohu8.com/highlight/detail?id=2537397890","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537397890?lang=en_us&edition=fundamental","pubTime":"2025-05-23 06:27","pubTimestamp":1747952874,"startTime":"0","endTime":"0","summary":"Steven C. Quay, President & CEO of Atossa Therapeutics Inc., reported an acquisition of common shares of Atossa Therapeutics Inc. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Atossa Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 22, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250522:nNDL9c4XCp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ATOS"],"gpt_icon":0},{"id":"2535264490","title":"Atossa Therapeutics Reports Promising Results from I-SPY 2 Trial Evaluating Low-Dose (Z)-Endoxifen in Breast Cancer Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2535264490","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535264490?lang=en_us&edition=fundamental","pubTime":"2025-05-14 20:15","pubTimestamp":1747224927,"startTime":"0","endTime":"0","summary":"Atossa Therapeutics Reports Promising Results from I-SPY 2 Trial Evaluating Low-Dose -Endoxifen in Breast Cancer Treatment. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Atossa Therapeutics Inc. published the original content used to generate this news brief via PR Newswire  on May 14, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250514:nNDL3X13p2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ATOS","BK4139"],"gpt_icon":0},{"id":"2535264260","title":"Atossa Therapeutics: Well‑Tolerated Safety Profile - Adverse Events Were Predominantly Grade 1","url":"https://stock-news.laohu8.com/highlight/detail?id=2535264260","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535264260?lang=en_us&edition=fundamental","pubTime":"2025-05-14 20:15","pubTimestamp":1747224916,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250514:nFWN3RM1SL:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ATOS"],"gpt_icon":0},{"id":"2535102492","title":"Atossa Therapeutics: Announces Full Results From I‑Spy 2 Endocrine‑Optimization Sub‑Study Evaluating Low‑Dose (Z)‑Endoxifen","url":"https://stock-news.laohu8.com/highlight/detail?id=2535102492","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535102492?lang=en_us&edition=fundamental","pubTime":"2025-05-14 20:15","pubTimestamp":1747224916,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250514:nFWN3RM1SL:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ATOS","BK4139"],"gpt_icon":0},{"id":"2535774572","title":"Atossa Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2535774572","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535774572?lang=en_us&edition=fundamental","pubTime":"2025-05-13 21:52","pubTimestamp":1747144364,"startTime":"0","endTime":"0","summary":"Atossa Therapeutics Inc reports results for the quarter ended March 31 - Earnings SummaryAtossa Therapeutics Inc ATOS.OQ reported a quarterly adjusted loss of 5 cents per share for the quarter ended M","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250513:nL8N3RL1Q2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ATOS"],"gpt_icon":0},{"id":"2535727264","title":"Atossa Therapeutics Q1 EPS $(0.05) Beats $(0.06) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2535727264","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535727264?lang=en_us&edition=fundamental","pubTime":"2025-05-13 20:06","pubTimestamp":1747137998,"startTime":"0","endTime":"0","summary":"Atossa Therapeutics (NASDAQ:ATOS) reported quarterly losses of $(0.05) per share which beat the analyst consensus estimate of $(0.06) by 16.67 percent. This is unchanged from the same period last year.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/05/45373031/atossa-therapeutics-q1-eps-0-05-beats-0-06-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ATOS","LENZ"],"gpt_icon":0},{"id":"2535672797","title":"Atossa Therapeutics Reports No Revenue and Increased Operating Expenses in Q1 2025 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2535672797","media":"Reuters","labels":["dataReport","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535672797?lang=en_us&edition=fundamental","pubTime":"2025-05-13 20:02","pubTimestamp":1747137725,"startTime":"0","endTime":"0","summary":"Atossa Therapeutics Inc., a clinical-stage biopharmaceutical company, announced its financial results for the first quarter ended March 31, 2025. The company reported no revenue for this period, similar to the same quarter in 2024. Operating expenses increased to $7.4 million from $7.0 million in the previous year, driven primarily by a $0.3 million rise in both research and development compensation expenses and professional fees for regulatory consulting services. Research and development expenses totaled $4.157 million, up from $3.748 million in the first quarter of 2024. Clinical and pre-clinical trial expenses saw a slight decrease of $0.1 million, attributed to reduced spending on -endoxifen trials. In a strategic update, Atossa announced plans to focus on the metastatic breast cancer indication for its lead program, -endoxifen. This decision underscores the company's commitment to addressing the unmet medical needs in metastatic breast cancer. The company also expanded its intell","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250513:nNDL5gF2c1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"Atossa Therapeutics Reports No Revenue and Increased Operating Expenses in Q1 2025 Results","news_tag":"dataReport,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ATOS"],"gpt_icon":0},{"id":"2535334727","title":"Atossa Therapeutics Q1 Operating Expenses USD 7.414 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2535334727","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535334727?lang=en_us&edition=fundamental","pubTime":"2025-05-13 20:00","pubTimestamp":1747137614,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250513:nPLX64DD5F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ATOS"],"gpt_icon":0},{"id":"2534431683","title":"Atossa Therapeutics Inc  expected to post a loss of 6 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2534431683","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534431683?lang=en_us&edition=fundamental","pubTime":"2025-05-09 23:12","pubTimestamp":1746803528,"startTime":"0","endTime":"0","summary":"Atossa Therapeutics Inc  expected to post a loss of6cents a share - Earnings Preview Atossa Therapeutics Inc ATOS.OQ ATOS.O is expected to show no change in quarterly revenue when it reports  results ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250509:nL8N3RH2ET:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ATOS"],"gpt_icon":0},{"id":"2533582842","title":"Atossa Therapeutics and Ainos Interviews Aired on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV","url":"https://stock-news.laohu8.com/highlight/detail?id=2533582842","media":"ACCESS Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533582842?lang=en_us&edition=fundamental","pubTime":"2025-05-05 21:00","pubTimestamp":1746450000,"startTime":"0","endTime":"0","summary":"ORLANDO, FL / ACCESS Newswire / May 5, 2025 / RedChip Companies aired interviews with Atossa Therapeutics, Inc.  and Ainos, Inc.  on the RedChip Small Stocks, Big Money show, a sponsored program on Bloomberg TV, on May 3. Bloomberg TV is available in an estimated 73 million homes across the U.S.Atossa Therapeutics, Inc.  is a clinical-stage biopharmaceutical company dedicated to transforming breast cancer treatment through innovative science and patient-focused solutions. The company's lead product candidate, -endoxifen, is a highly potent SERM designed for use across the breast cancer spectrum, including prevention, neoadjuvant, adjuvant, and metastatic settings. Atossa is committed to advancing","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/atossa-therapeutics-ainos-interviews-aired-130000789.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4604","03160","TV","BK4551","BK4100","BK4548","BK4555","TM","BK4139","BK4099","LENZ","BK4588","BK4007","BK4079","Z","AIMD","BK4585","ATOS","AIMDW"],"gpt_icon":0},{"id":"2532068430","title":"Atossa Therapeutics Gets US Patent Covering (Z)-endoxifen Breast Cancer Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2532068430","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532068430?lang=en_us&edition=fundamental","pubTime":"2025-04-30 23:41","pubTimestamp":1746027717,"startTime":"0","endTime":"0","summary":"Atossa Therapeutics  said Wednesday that the US Patent and Trademark Office granted a new patent covering highly pure and stable enteric oral formulations of -endoxifen, a breast cancer treatmentThe patent includes 58 claims, encompassing various formulations and therapeutic methods for hormone-dependent breast and reproductive tract disorders, the company said.Atossa shares rose 1.9% in recent Wednesday trading.Price: 0.81, Change: +0.02, Percent Change: +1.89","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4551","BK4548","BK4079","LENZ","BK4585","BK4139","BK4588","ATOS","Z","BK4007"],"gpt_icon":0},{"id":"2531309387","title":"Atossa Therapeutics Proposes Potentially Groundbreaking Study Aimed at Reducing Interval Breast Cancer in High-Risk Women at AACR 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2531309387","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531309387?lang=en_us&edition=fundamental","pubTime":"2025-04-29 20:45","pubTimestamp":1745930700,"startTime":"0","endTime":"0","summary":"SEATTLE, April 29, 2025  -- Atossa Therapeutics, Inc.  , a clinical-stage biopharmaceutical company developing innovative medicines for breast cancer, today outlined a framework for a pioneering Phase 3 clinical study titled SMART 2.0. The proposed trial would investigate the potential of oral -endoxifen, a potent Selective Estrogen Receptor Modulator  for estrogen receptor inhibition, to significantly reduce interval breast cancer in women identified as high-risk through advanced mammographic screening techniques. The proposed SMART 2.0 study was presented at the American Association for Cancer Research  Annual Meeting and represents a future research program and potential partnership opportunity to advance this critical initiative for women at high risk of breast cancer.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/atossa-therapeutics-proposes-potentially-groundbreaking-124500381.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["E","ATOS","BK4588","BK4548","BK4139","BK4007","BK4079","Z","LENZ","BK4585","BK4551","BK4201"],"gpt_icon":0},{"id":"2529078053","title":"Atossa Therapeutics announces issuance of U.S. patent","url":"https://stock-news.laohu8.com/highlight/detail?id=2529078053","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529078053?lang=en_us&edition=fundamental","pubTime":"2025-04-22 20:50","pubTimestamp":1745326240,"startTime":"0","endTime":"0","summary":"Atossa Therapeutics (ATOS) announced that the United States Patent and Trademark Office has granted a new patent directed to enteric oral formulati...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/atossa-therapeutics-announces-issuance-of-u-s-patent?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/atossa-therapeutics-announces-issuance-of-u-s-patent?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","BK4007","BK4139","ATOS"],"gpt_icon":0},{"id":"2529958810","title":"Atossa Therapeutics Announces Issuance of U.S. Patent No. 12,275,684, Further Strengthening (Z)-endoxifen Portfolio","url":"https://stock-news.laohu8.com/highlight/detail?id=2529958810","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529958810?lang=en_us&edition=fundamental","pubTime":"2025-04-22 20:45","pubTimestamp":1745325900,"startTime":"0","endTime":"0","summary":"SEATTLE, April 22, 2025  -- Atossa Therapeutics, Inc.  , a clinical-stage biopharmaceutical company developing innovative medicines for breast cancer, today announced that the United States Patent and Trademark Office  has granted a new patent  directed to enteric oral formulations comprising -endoxifen as well as methods of treating subjects with those oral formulations.This newly granted patent further fortifies Atossa’s intellectual property portfolio surrounding its proprietary -endoxifen formulations, encompassing novel compositions and methods related to -endoxifen, a potent Selective Estrogen Receptor Modulator . Specifically, the patent covers enteric oral formulations of -endoxifen and salts thereof as well as their use in treating hormone-dependent breast and reproductive tract disorders.Atossa is developing a proprietary oral formulation of -endoxifen that is encapsulated to bypass the stomach, as acidic conditions in the stomach convert a significant proportion of -endoxife","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/atossa-therapeutics-announces-issuance-u-124500642.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4079","BK4588","BK4551","BK4139","E","LENZ","Z","BK4548","BK4585","BK4007","ATOS","BK4201"],"gpt_icon":0},{"id":"2529963876","title":"Atossa Therapeutics Is Maintained at Buy by Ascendiant Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2529963876","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529963876?lang=en_us&edition=fundamental","pubTime":"2025-04-21 18:17","pubTimestamp":1745230620,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ATOS/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 21, 2025 06:17 ET (10:17 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ATOS","LENZ"],"gpt_icon":0},{"id":"2526456528","title":"Nona Biosciences and Atossa Therapeutics Partner to Discover Next-Generation Antibody Therapies for Breast Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2526456528","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526456528?lang=en_us&edition=fundamental","pubTime":"2025-04-10 20:00","pubTimestamp":1744286400,"startTime":"0","endTime":"0","summary":"CAMBRIDGE, Mass., April 10, 2025 /PRNewswire/ -- Nona Biosciences, a global biotechnology company providing integrated solutions from \"Idea to IND\" , ranging from target validation and antibody discovery through preclinical research, today announced a research collaboration with Atossa Therapeutics Inc. . The collaboration leverages Nona's proprietary H2L2 Harbour Mice platform to identify next-generation therapeutic candidatesfor breast cancer.Nona Biosciences is a global biotechnology company committed to cutting-edge technology innovations and providing a total solution from \"Idea to IND\" ,ranging from target validation and antibody discovery through preclinical research. The integrated antibody and antibody-related discovery services with multiple modalities range from antigen preparation, animal immunization, single B cell screening, to antibody lead generation and engineering, developability assessment and pharmacological evaluation, leveraging advantages of Harbour Miceplatforms","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/nona-biosciences-atossa-therapeutics-partner-120000938.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/nona-biosciences-atossa-therapeutics-partner-120000938.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ATOS","DFS","LU2360107671.USD","BK4166","BK4588","LU1791807156.HKD","LU1861220207.SGD","LU0106831901.USD","BK4139","BK4585","LU1861217088.USD","LU1668664300.SGD","LENZ","BK4007"],"gpt_icon":0},{"id":"2525076017","title":"BRIEF-Atossa Therapeutics says Intas Pharmaceuticals Filed Petition For Post Grant Review Against Co- SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2525076017","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525076017?lang=en_us&edition=fundamental","pubTime":"2025-04-08 04:24","pubTimestamp":1744057449,"startTime":"0","endTime":"0","summary":"BRIEF-Atossa Therapeutics says Intas Pharmaceuticals Filed Petition For Post Grant Review Against Co- SEC FilingApril 7  - Atossa Therapeutics Inc ATOS.O:ATOSSA THERAPEUTICS INC - INTAS PHARMACEUTICALS FILES PETITION FOR POST GRANT REVIEW AGAINST CO- SEC FILINGATOSSA THERAPEUTICS INC - INTAS PHARMACEUTICALS FILES PETITION FOR INTER PARTES REVIEW AGAINST COATOSSA THERAPEUTICS INC - TO CONTEST PGR AND IPR PETITIONS - SEC FILINGSource text: [ID:n0000950170-25-051575]Further company coverage: ATOS.O ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250407:nFWN3QL1N6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ATOS"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":51,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ATOS\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-13","symbol":"ATOS","fiscalQuarterEnding":"2025/03","expectedEps":-0.06,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1747108800000,"reportTimeType":"pre","actualEps":-0.05},{"market":"US","date":"2025-03-25","symbol":"ATOS","fiscalQuarterEnding":"2024/12","expectedEps":-0.06,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1742875200000,"reportTimeType":"pre","actualEps":-0.05},{"market":"US","date":"2024-11-12","symbol":"ATOS","fiscalQuarterEnding":"2024/09","expectedEps":-0.06,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1731387600000,"reportTimeType":"pre","actualEps":-0.05},{"market":"US","date":"2024-08-12","symbol":"ATOS","fiscalQuarterEnding":"2024/06","expectedEps":-0.05,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1723435200000,"reportTimeType":"pre","actualEps":-0.05},{"market":"US","date":"2024-05-13","symbol":"ATOS","fiscalQuarterEnding":"2024/03","expectedEps":-0.07,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1715572800000,"reportTimeType":"pre","actualEps":-0.05}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ATOS\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ATOS\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":4,"updateTime":1749355200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ATOS\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ATOS","date":"2025-06-13","current":-4.230484,"percent":0.599513,"low":-56.54649,"twenty":-8.711157,"median":-5.042039,"eighty":-3.19945,"high":-1.108148,"avg":-7.456425,"sd":7.217819,"marketCap":111447879},"quantilePoints":[{"date":"2020-06-19","current":-1.817246,"twenty":-1.654454,"median":-0.841705,"eighty":-0.481914,"marketCap":29282896},{"date":"2020-06-26","current":-2.274414,"twenty":-1.654454,"median":-0.841705,"eighty":-0.481914,"marketCap":36649662},{"date":"2020-07-02","current":-2.125834,"twenty":-1.654454,"median":-0.841705,"eighty":-0.481914,"marketCap":34255463},{"date":"2020-07-10","current":-2.108691,"twenty":-1.654454,"median":-0.841705,"eighty":-0.481914,"marketCap":33979210},{"date":"2020-07-17","current":-2.422994,"twenty":-1.654454,"median":-0.841705,"eighty":-0.481914,"marketCap":39043861},{"date":"2020-07-24","current":-2.19441,"twenty":-1.654454,"median":-0.841705,"eighty":-0.481914,"marketCap":35360478},{"date":"2020-07-31","current":-2.160122,"twenty":-1.654454,"median":-0.841705,"eighty":-0.481914,"marketCap":34807971},{"date":"2020-08-07","current":-2.188695,"twenty":-1.654454,"median":-0.841705,"eighty":-0.481914,"marketCap":35268394},{"date":"2020-08-14","current":-3.022962,"twenty":-1.654454,"median":-0.841705,"eighty":-0.481914,"marketCap":38565453},{"date":"2020-08-21","current":-2.754074,"twenty":-1.654454,"median":-0.841705,"eighty":-0.481914,"marketCap":35135103},{"date":"2020-08-28","current":-2.142963,"twenty":-1.654454,"median":-0.841705,"eighty":-0.481914,"marketCap":27338852},{"date":"2020-09-04","current":-1.686666,"twenty":-1.654454,"median":-0.841705,"eighty":-0.481914,"marketCap":21517652},{"date":"2020-09-11","current":-1.613333,"twenty":-1.644408,"median":-0.841705,"eighty":-0.481914,"marketCap":20582101},{"date":"2020-09-18","current":-1.988148,"twenty":-1.644408,"median":-0.841705,"eighty":-0.481914,"marketCap":25363802},{"date":"2020-09-25","current":-1.971852,"twenty":-1.644408,"median":-0.841705,"eighty":-0.481914,"marketCap":25155902},{"date":"2020-10-02","current":-1.955555,"twenty":-1.644408,"median":-0.841705,"eighty":-0.481914,"marketCap":24948002},{"date":"2020-10-09","current":-1.898518,"twenty":-1.644408,"median":-0.841705,"eighty":-0.481914,"marketCap":24220352},{"date":"2020-10-16","current":-1.719259,"twenty":-1.644408,"median":-0.841705,"eighty":-0.481914,"marketCap":21933452},{"date":"2020-10-23","current":-1.491111,"twenty":-1.6421,"median":-0.841705,"eighty":-0.481914,"marketCap":19022851},{"date":"2020-10-30","current":-1.214074,"twenty":-1.636347,"median":-0.841705,"eighty":-0.481914,"marketCap":15488551},{"date":"2020-11-06","current":-1.271111,"twenty":-1.63366,"median":-0.841705,"eighty":-0.481914,"marketCap":16216201},{"date":"2020-11-13","current":-1.270862,"twenty":-1.621509,"median":-0.841705,"eighty":-0.481914,"marketCap":16473750},{"date":"2020-11-20","current":-1.246578,"twenty":-1.617468,"median":-0.841705,"eighty":-0.481914,"marketCap":16158965},{"date":"2020-11-27","current":-1.408471,"twenty":-1.617468,"median":-0.841705,"eighty":-0.481914,"marketCap":18257532},{"date":"2020-12-04","current":-2.862097,"twenty":-1.63366,"median":-0.841705,"eighty":-0.481914,"marketCap":37100395},{"date":"2020-12-11","current":-1.682449,"twenty":-1.644408,"median":-0.841705,"eighty":-0.481914,"marketCap":21809016},{"date":"2020-12-18","current":-1.642999,"twenty":-1.654454,"median":-0.841705,"eighty":-0.481914,"marketCap":21297632},{"date":"2020-12-24","current":-2.664265,"twenty":-1.66859,"median":-0.841705,"eighty":-0.481914,"marketCap":34535966},{"date":"2020-12-31","current":-2.863181,"twenty":-1.683775,"median":-0.841705,"eighty":-0.481914,"marketCap":37114443},{"date":"2021-01-08","current":-5.282209,"twenty":-1.686108,"median":-0.84178,"eighty":-0.481914,"marketCap":68471482},{"date":"2021-01-15","current":-6.885049,"twenty":-1.692773,"median":-0.842439,"eighty":-0.481914,"marketCap":89248543},{"date":"2021-01-22","current":-10.300033,"twenty":-1.703499,"median":-0.845174,"eighty":-0.481914,"marketCap":133515821},{"date":"2021-01-29","current":-12.172766,"twenty":-1.715926,"median":-0.847527,"eighty":-0.481914,"marketCap":157791425},{"date":"2021-02-05","current":-21.478921,"twenty":-1.732601,"median":-0.848569,"eighty":-0.481914,"marketCap":278423949},{"date":"2021-02-12","current":-20.098528,"twenty":-1.745522,"median":-0.852003,"eighty":-0.481914,"marketCap":260530379},{"date":"2021-02-19","current":-17.172094,"twenty":-1.751452,"median":-0.852232,"eighty":-0.481914,"marketCap":222596010},{"date":"2021-02-26","current":-15.01868,"twenty":-1.773381,"median":-0.852232,"eighty":-0.481914,"marketCap":194682041},{"date":"2021-03-05","current":-12.313109,"twenty":-1.783844,"median":-0.852043,"eighty":-0.481618,"marketCap":159610644},{"date":"2021-03-12","current":-16.067779,"twenty":-1.817246,"median":-0.852421,"eighty":-0.481618,"marketCap":208281154},{"date":"2021-03-19","current":-15.349974,"twenty":-1.829769,"median":-0.853652,"eighty":-0.481618,"marketCap":198976498},{"date":"2021-03-26","current":-14.819522,"twenty":-1.836981,"median":-0.855734,"eighty":-0.481914,"marketCap":192100420},{"date":"2021-04-01","current":-14.638806,"twenty":-1.850765,"median":-0.855734,"eighty":-0.481914,"marketCap":260980634},{"date":"2021-04-09","current":-13.689995,"twenty":-1.873373,"median":-0.858429,"eighty":-0.481618,"marketCap":244065223},{"date":"2021-04-16","current":-11.046877,"twenty":-1.897673,"median":-0.863848,"eighty":-0.481618,"marketCap":196943719},{"date":"2021-04-23","current":-11.995688,"twenty":-1.909665,"median":-0.867984,"eighty":-0.481618,"marketCap":213859131},{"date":"2021-04-30","current":-15.790934,"twenty":-1.922392,"median":-0.868606,"eighty":-0.481618,"marketCap":281520777},{"date":"2021-05-07","current":-18.569597,"twenty":-1.952976,"median":-0.869364,"eighty":-0.481618,"marketCap":331058768},{"date":"2021-05-14","current":-19.023761,"twenty":-1.97085,"median":-0.879213,"eighty":-0.481618,"marketCap":350390667},{"date":"2021-05-21","current":-21.188534,"twenty":-1.984771,"median":-0.8803,"eighty":-0.481618,"marketCap":390262708},{"date":"2021-05-28","current":-21.122935,"twenty":-2.009032,"median":-0.885764,"eighty":-0.481618,"marketCap":389054464},{"date":"2021-06-04","current":-30.30682,"twenty":-2.028564,"median":-0.885764,"eighty":-0.481618,"marketCap":558208580},{"date":"2021-06-11","current":-28.273245,"twenty":-2.039544,"median":-0.885768,"eighty":-0.481618,"marketCap":520753026},{"date":"2021-06-18","current":-35.095559,"twenty":-2.055075,"median":-0.895581,"eighty":-0.481618,"marketCap":646410368},{"date":"2021-06-25","current":-56.54649,"twenty":-2.067664,"median":-0.905057,"eighty":-0.481618,"marketCap":1041506052},{"date":"2021-07-02","current":-35.226758,"twenty":-2.087317,"median":-0.911656,"eighty":-0.481618,"marketCap":648826856},{"date":"2021-07-09","current":-34.898762,"twenty":-2.107728,"median":-0.917115,"eighty":-0.481618,"marketCap":642785637},{"date":"2021-07-16","current":-29.519629,"twenty":-2.115375,"median":-0.922574,"eighty":-0.481618,"marketCap":543709656},{"date":"2021-07-23","current":-27.420456,"twenty":-2.139537,"median":-0.934503,"eighty":-0.481618,"marketCap":505045858},{"date":"2021-07-30","current":-20.525084,"twenty":-2.160122,"median":-0.943574,"eighty":-0.481618,"marketCap":378042910},{"date":"2021-08-06","current":-23.202269,"twenty":-2.173818,"median":-0.944411,"eighty":-0.481618,"marketCap":427352855},{"date":"2021-08-13","current":-18.918779,"twenty":-2.194723,"median":-0.955329,"eighty":-0.481618,"marketCap":407726884},{"date":"2021-08-20","current":-19.153794,"twenty":-2.213427,"median":-0.966247,"eighty":-0.481618,"marketCap":412791814},{"date":"2021-08-27","current":-21.915231,"twenty":-2.238204,"median":-0.971483,"eighty":-0.481618,"marketCap":472304744},{"date":"2021-09-03","current":-22.032739,"twenty":-2.260964,"median":-0.978233,"eighty":-0.482893,"marketCap":474837210},{"date":"2021-09-10","current":-23.325326,"twenty":-2.270037,"median":-0.992208,"eighty":-0.482893,"marketCap":502694326},{"date":"2021-09-17","current":-21.033922,"twenty":-2.288598,"median":-0.993831,"eighty":-0.482893,"marketCap":453311256},{"date":"2021-09-24","current":-19.858842,"twenty":-2.306658,"median":-1.000057,"eighty":-0.482893,"marketCap":427986605},{"date":"2021-10-01","current":-19.095041,"twenty":-2.376607,"median":-1.011331,"eighty":-0.482893,"marketCap":411525582},{"date":"2021-10-08","current":-18.683763,"twenty":-2.40205,"median":-1.018076,"eighty":-0.482983,"marketCap":402661954},{"date":"2021-10-15","current":-16.803636,"twenty":-2.425515,"median":-1.028048,"eighty":-0.488626,"marketCap":362142512},{"date":"2021-10-22","current":-16.333604,"twenty":-2.462678,"median":-1.035775,"eighty":-0.497592,"marketCap":352012651},{"date":"2021-10-29","current":-15.09977,"twenty":-2.503041,"median":-1.055103,"eighty":-0.507425,"marketCap":325421767},{"date":"2021-11-05","current":-16.098588,"twenty":-2.562582,"median":-1.072428,"eighty":-0.531824,"marketCap":346947721},{"date":"2021-11-12","current":-15.569802,"twenty":-2.611254,"median":-1.079106,"eighty":-0.553119,"marketCap":335551628},{"date":"2021-11-19","current":-12.794512,"twenty":-2.659443,"median":-1.085262,"eighty":-0.568693,"marketCap":297566658},{"date":"2021-11-26","current":-12.413399,"twenty":-2.727565,"median":-1.09038,"eighty":-0.575917,"marketCap":288702970},{"date":"2021-12-03","current":-10.507833,"twenty":-2.792997,"median":-1.097263,"eighty":-0.587588,"marketCap":244384532},{"date":"2021-12-10","current":-10.943391,"twenty":-2.856481,"median":-1.099625,"eighty":-0.599728,"marketCap":254514461},{"date":"2021-12-17","current":-10.725612,"twenty":-2.905335,"median":-1.108181,"eighty":-0.610945,"marketCap":249449496},{"date":"2021-12-23","current":-9.800052,"twenty":-2.974256,"median":-1.108562,"eighty":-0.624983,"marketCap":227923398},{"date":"2021-12-31","current":-8.711157,"twenty":-3.128969,"median":-1.114803,"eighty":-0.633499,"marketCap":202598576},{"date":"2022-01-07","current":-8.330044,"twenty":-5.482702,"median":-1.119099,"eighty":-0.644504,"marketCap":193734888},{"date":"2022-01-14","current":-7.948931,"twenty":-7.201712,"median":-1.123862,"eighty":-0.651457,"marketCap":184871200},{"date":"2022-01-21","current":-6.860036,"twenty":-7.611374,"median":-1.135476,"eighty":-0.660331,"marketCap":159546378},{"date":"2022-01-28","current":-6.751147,"twenty":-7.589596,"median":-1.145579,"eighty":-0.668417,"marketCap":157013896},{"date":"2022-02-04","current":-6.805591,"twenty":-7.589596,"median":-1.150539,"eighty":-0.673229,"marketCap":158280137},{"date":"2022-02-11","current":-7.404483,"twenty":-7.738189,"median":-1.157174,"eighty":-0.683463,"marketCap":172208789},{"date":"2022-02-18","current":-6.860036,"twenty":-7.738189,"median":-1.172103,"eighty":-0.688731,"marketCap":159546378},{"date":"2022-02-25","current":-6.805591,"twenty":-7.738189,"median":-1.187337,"eighty":-0.703334,"marketCap":158280137},{"date":"2022-03-04","current":-7.435464,"twenty":-7.956848,"median":-1.20507,"eighty":-0.709225,"marketCap":153215173},{"date":"2022-03-11","current":-7.435464,"twenty":-7.991487,"median":-1.215898,"eighty":-0.717544,"marketCap":153215173},{"date":"2022-03-18","current":-9.586218,"twenty":-8.062425,"median":-1.232652,"eighty":-0.722939,"marketCap":197533611},{"date":"2022-03-25","current":-8.848817,"twenty":-8.340933,"median":-1.245717,"eighty":-0.724233,"marketCap":182338718},{"date":"2022-04-01","current":-7.619814,"twenty":-8.430956,"median":-1.256015,"eighty":-0.732518,"marketCap":157013896},{"date":"2022-04-08","current":-7.066763,"twenty":-8.430956,"median":-1.270862,"eighty":-0.742242,"marketCap":145617726},{"date":"2022-04-14","current":-6.820963,"twenty":-8.430956,"median":-1.279552,"eighty":-0.746236,"marketCap":140552762},{"date":"2022-04-22","current":-6.267912,"twenty":-8.430956,"median":-1.303703,"eighty":-0.748228,"marketCap":129156592},{"date":"2022-04-29","current":-6.206462,"twenty":-8.430956,"median":-1.343511,"eighty":-0.753216,"marketCap":127890351},{"date":"2022-05-06","current":-6.057138,"twenty":-8.430956,"median":-1.407132,"eighty":-0.754543,"marketCap":124813385},{"date":"2022-05-13","current":-5.714714,"twenty":-8.430956,"median":-1.428042,"eighty":-0.756108,"marketCap":124889359},{"date":"2022-05-20","current":-5.558853,"twenty":-8.430956,"median":-1.503333,"eighty":-0.758684,"marketCap":121483171},{"date":"2022-05-27","current":-5.550741,"twenty":-8.430956,"median":-1.561647,"eighty":-0.762567,"marketCap":121305897},{"date":"2022-06-03","current":-5.909975,"twenty":-8.430956,"median":-1.621295,"eighty":-0.76678,"marketCap":129156592},{"date":"2022-06-10","current":-6.547325,"twenty":-8.430956,"median":-1.636347,"eighty":-0.77591,"marketCap":143085244},{"date":"2022-06-17","current":-6.025857,"twenty":-8.430956,"median":-1.644408,"eighty":-0.78054,"marketCap":131689074},{"date":"2022-06-24","current":-6.779089,"twenty":-8.443246,"median":-1.662719,"eighty":-0.783078,"marketCap":148150208},{"date":"2022-07-01","current":-5.852034,"twenty":-8.443246,"median":-1.676651,"eighty":-0.787472,"marketCap":127890351},{"date":"2022-07-08","current":-6.25762,"twenty":-8.443246,"median":-1.684712,"eighty":-0.79295,"marketCap":136754038},{"date":"2022-07-15","current":-5.967916,"twenty":-8.443246,"median":-1.688742,"eighty":-0.79638,"marketCap":130422833},{"date":"2022-07-22","current":-5.69907,"twenty":-8.443246,"median":-1.700833,"eighty":-0.80382,"marketCap":124547474},{"date":"2022-07-29","current":-5.452821,"twenty":-8.443246,"median":-1.708894,"eighty":-0.807837,"marketCap":119165949},{"date":"2022-08-05","current":-5.794093,"twenty":-8.443246,"median":-1.724621,"eighty":-0.811954,"marketCap":126624110},{"date":"2022-08-12","current":-6.364797,"twenty":-8.443246,"median":-1.742956,"eighty":-0.815655,"marketCap":136754038},{"date":"2022-08-19","current":-5.952264,"twenty":-8.443246,"median":-1.751852,"eighty":-0.820778,"marketCap":127890351},{"date":"2022-08-26","current":-5.654651,"twenty":-8.443246,"median":-1.773381,"eighty":-0.82749,"marketCap":121495833},{"date":"2022-09-02","current":-5.379433,"twenty":-8.443246,"median":-1.784444,"eighty":-0.831091,"marketCap":115582487},{"date":"2022-09-09","current":-5.569198,"twenty":-8.443246,"median":-1.817246,"eighty":-0.836558,"marketCap":119659783},{"date":"2022-09-16","current":-5.486102,"twenty":-8.443246,"median":-1.829618,"eighty":-0.841631,"marketCap":117874383},{"date":"2022-09-23","current":-4.857873,"twenty":-8.443246,"median":-1.835652,"eighty":-0.842026,"marketCap":104376253},{"date":"2022-09-30","current":-4.910913,"twenty":-8.443246,"median":-1.853989,"eighty":-0.844965,"marketCap":105515870},{"date":"2022-10-07","current":-4.780081,"twenty":-8.443246,"median":-1.874074,"eighty":-0.847792,"marketCap":102704815},{"date":"2022-10-14","current":-4.773598,"twenty":-8.443246,"median":-1.898518,"eighty":-0.850625,"marketCap":102565529},{"date":"2022-10-21","current":-4.832531,"twenty":-8.443246,"median":-1.910415,"eighty":-0.852421,"marketCap":103831770},{"date":"2022-10-28","current":-5.775464,"twenty":-8.443246,"median":-1.922963,"eighty":-0.857816,"marketCap":124091627},{"date":"2022-11-04","current":-5.043513,"twenty":-8.443246,"median":-1.955555,"eighty":-0.863323,"marketCap":108364913},{"date":"2022-11-11","current":-4.377471,"twenty":-8.443246,"median":-1.971852,"eighty":-0.868357,"marketCap":106376914},{"date":"2022-11-18","current":-4.150807,"twenty":-8.443246,"median":-1.985886,"eighty":-0.868357,"marketCap":100868766},{"date":"2022-11-25","current":-4.272737,"twenty":-8.443246,"median":-2.000113,"eighty":-0.868357,"marketCap":103831770},{"date":"2022-12-02","current":-3.987714,"twenty":-8.443246,"median":-2.029426,"eighty":-0.868357,"marketCap":96905431},{"date":"2022-12-09","current":-3.484365,"twenty":-8.443246,"median":-2.040115,"eighty":-0.868357,"marketCap":84673542},{"date":"2022-12-16","current":-3.03729,"twenty":-8.443246,"median":-2.05551,"eighty":-0.868357,"marketCap":73809193},{"date":"2022-12-23","current":-3.000295,"twenty":-8.443246,"median":-2.068688,"eighty":-0.868808,"marketCap":72910162},{"date":"2022-12-30","current":-2.753831,"twenty":-8.443246,"median":-2.085832,"eighty":-0.871143,"marketCap":66920842},{"date":"2023-01-06","current":-3.746981,"twenty":-8.443246,"median":-2.103874,"eighty":-0.871143,"marketCap":91055397},{"date":"2023-01-13","current":-4.446251,"twenty":-8.443246,"median":-2.114405,"eighty":-0.871143,"marketCap":108048353},{"date":"2023-01-20","current":-4.202914,"twenty":-8.443246,"median":-2.12012,"eighty":-0.871143,"marketCap":102135007},{"date":"2023-01-27","current":-4.272737,"twenty":-8.443246,"median":-2.152172,"eighty":-0.871143,"marketCap":103831770},{"date":"2023-02-03","current":-4.324843,"twenty":-8.443246,"median":-2.160122,"eighty":-0.871143,"marketCap":105098011},{"date":"2023-02-10","current":-3.782935,"twenty":-8.443246,"median":-2.170132,"eighty":-0.871143,"marketCap":91929103},{"date":"2023-02-17","current":-4.180508,"twenty":-8.443246,"median":-2.171551,"eighty":-0.871143,"marketCap":101590523},{"date":"2023-02-24","current":-3.885585,"twenty":-8.443246,"median":-2.174385,"eighty":-0.871143,"marketCap":94423598},{"date":"2023-03-03","current":-3.739687,"twenty":-8.443246,"median":-2.174385,"eighty":-0.871143,"marketCap":90878123},{"date":"2023-03-10","current":-3.51615,"twenty":-8.443246,"median":-2.174385,"eighty":-0.871143,"marketCap":85445949},{"date":"2023-03-17","current":-3.595351,"twenty":-8.443246,"median":-2.188695,"eighty":-0.871143,"marketCap":87370635},{"date":"2023-03-24","current":-3.27081,"twenty":-8.443246,"median":-2.211554,"eighty":-0.871143,"marketCap":88181030},{"date":"2023-03-31","current":-3.404667,"twenty":-8.430956,"median":-2.238858,"eighty":-0.871736,"marketCap":91789817},{"date":"2023-04-06","current":-3.354412,"twenty":-8.430956,"median":-2.265842,"eighty":-0.871736,"marketCap":90434939},{"date":"2023-04-14","current":-3.474648,"twenty":-8.443246,"median":-2.285844,"eighty":-0.871143,"marketCap":93676516},{"date":"2023-04-21","current":-3.362866,"twenty":-8.443246,"median":-2.361747,"eighty":-0.871143,"marketCap":90662862},{"date":"2023-04-28","current":-2.975854,"twenty":-8.443246,"median":-2.393989,"eighty":-0.871143,"marketCap":80229036},{"date":"2023-05-05","current":-3.179223,"twenty":-8.443246,"median":-2.418171,"eighty":-0.871143,"marketCap":85711860},{"date":"2023-05-12","current":-3.2121,"twenty":-8.443246,"median":-2.472437,"eighty":-0.871143,"marketCap":86598228},{"date":"2023-05-19","current":-3.172389,"twenty":-8.443246,"median":-2.517777,"eighty":-0.871143,"marketCap":90270328},{"date":"2023-05-26","current":-4.297343,"twenty":-8.443246,"median":-2.651908,"eighty":-0.871143,"marketCap":122280903},{"date":"2023-06-02","current":-4.105104,"twenty":-8.443246,"median":-2.695007,"eighty":-0.871143,"marketCap":116810741},{"date":"2023-06-09","current":-4.338283,"twenty":-8.455536,"median":-2.753953,"eighty":-0.87055,"marketCap":123445844},{"date":"2023-06-16","current":-3.99964,"twenty":-8.455536,"median":-2.805078,"eighty":-0.875188,"marketCap":113809750},{"date":"2023-06-23","current":-4.05393,"twenty":-8.467826,"median":-2.839179,"eighty":-0.879396,"marketCap":115354564},{"date":"2023-06-30","current":-5.695971,"twenty":-8.480116,"median":-2.863181,"eighty":-0.884791,"marketCap":162078860},{"date":"2023-07-07","current":-5.473472,"twenty":-8.480116,"median":-2.935338,"eighty":-0.885768,"marketCap":155747655},{"date":"2023-07-14","current":-5.384473,"twenty":-8.480116,"median":-2.980152,"eighty":-0.895581,"marketCap":153215173},{"date":"2023-07-21","current":-5.072974,"twenty":-8.480116,"median":-3.014438,"eighty":-0.910372,"marketCap":144351485},{"date":"2023-07-28","current":-4.627977,"twenty":-8.480116,"median":-3.043022,"eighty":-0.917161,"marketCap":131689074},{"date":"2023-08-04","current":-4.805976,"twenty":-8.480116,"median":-3.123955,"eighty":-0.933492,"marketCap":136754038},{"date":"2023-08-11","current":-4.583477,"twenty":-8.480116,"median":-3.172611,"eighty":-0.944411,"marketCap":130422833},{"date":"2023-08-18","current":-3.510877,"twenty":-8.480116,"median":-3.196041,"eighty":-0.944411,"marketCap":110992860},{"date":"2023-08-25","current":-3.480638,"twenty":-8.480116,"median":-3.230264,"eighty":-0.944411,"marketCap":110036892},{"date":"2023-09-01","current":-3.14284,"twenty":-8.480116,"median":-3.276761,"eighty":-0.944411,"marketCap":99357729},{"date":"2023-09-08","current":-2.958224,"twenty":-8.480116,"median":-3.276761,"eighty":-0.944411,"marketCap":93521296},{"date":"2023-09-15","current":-3.143237,"twenty":-8.480116,"median":-3.287059,"eighty":-0.944411,"marketCap":99370308},{"date":"2023-09-22","current":-3.143237,"twenty":-8.480116,"median":-3.287059,"eighty":-0.955329,"marketCap":99370308},{"date":"2023-09-29","current":-3.00398,"twenty":-8.480116,"median":-3.287483,"eighty":-0.999001,"marketCap":94967826},{"date":"2023-10-06","current":-2.851593,"twenty":-8.480116,"median":-3.287483,"eighty":-1.022217,"marketCap":90150252},{"date":"2023-10-13","current":-2.64589,"twenty":-8.480116,"median":-3.287483,"eighty":-1.080886,"marketCap":83647158},{"date":"2023-10-20","current":-2.625996,"twenty":-8.480116,"median":-3.287483,"eighty":-1.097263,"marketCap":83018232},{"date":"2023-10-27","current":-2.672548,"twenty":-8.481474,"median":-3.302389,"eighty":-1.107436,"marketCap":84489918},{"date":"2023-11-03","current":-2.77719,"twenty":-8.481474,"median":-3.302389,"eighty":-1.108181,"marketCap":87798069},{"date":"2023-11-10","current":-2.637932,"twenty":-8.481474,"median":-3.302389,"eighty":-1.118172,"marketCap":83395587},{"date":"2023-11-17","current":-2.866862,"twenty":-8.481474,"median":-3.302389,"eighty":-1.123293,"marketCap":85521357},{"date":"2023-11-24","current":-3.317947,"twenty":-8.481474,"median":-3.31355,"eighty":-1.135476,"marketCap":98977680},{"date":"2023-12-01","current":-3.121365,"twenty":-8.481474,"median":-3.317947,"eighty":-1.148578,"marketCap":93113449},{"date":"2023-12-08","current":-3.092802,"twenty":-8.481022,"median":-3.31733,"eighty":-1.157037,"marketCap":92261382},{"date":"2023-12-15","current":-3.065919,"twenty":-8.481022,"median":-3.31733,"eighty":-1.172421,"marketCap":91459436},{"date":"2023-12-22","current":-3.087342,"twenty":-8.481022,"median":-3.31733,"eighty":-1.199689,"marketCap":92098487},{"date":"2023-12-29","current":-4.100074,"twenty":-8.481474,"median":-3.320595,"eighty":-1.222251,"marketCap":122309296},{"date":"2024-01-05","current":-3.822423,"twenty":-8.481927,"median":-3.36404,"eighty":-1.247562,"marketCap":114026698},{"date":"2024-01-12","current":-3.79344,"twenty":-8.481927,"median":-3.386925,"eighty":-1.264543,"marketCap":113162100},{"date":"2024-01-19","current":-3.427579,"twenty":-8.48238,"median":-3.404667,"eighty":-1.279259,"marketCap":102248116},{"date":"2024-01-26","current":-3.360372,"twenty":-8.481927,"median":-3.420279,"eighty":-1.305834,"marketCap":100243251},{"date":"2024-02-02","current":-3.52671,"twenty":-8.481927,"median":-3.444381,"eighty":-1.36922,"marketCap":105205292},{"date":"2024-02-09","current":-3.948437,"twenty":-8.481927,"median":-3.461454,"eighty":-1.496,"marketCap":117785820},{"date":"2024-02-16","current":-4.242469,"twenty":-8.481927,"median":-3.475353,"eighty":-1.58074,"marketCap":126557104},{"date":"2024-02-23","current":-4.284474,"twenty":-8.481927,"median":-3.490779,"eighty":-1.630973,"marketCap":127810145},{"date":"2024-03-01","current":-4.103854,"twenty":-8.481474,"median":-3.509376,"eighty":-1.643563,"marketCap":122422070},{"date":"2024-03-08","current":-4.620511,"twenty":-8.481474,"median":-3.526647,"eighty":-1.652044,"marketCap":137834470},{"date":"2024-03-15","current":-5.040558,"twenty":-8.481474,"median":-3.544287,"eighty":-1.672882,"marketCap":150364876},{"date":"2024-03-22","current":-7.056781,"twenty":-8.481474,"median":-3.592657,"eighty":-1.672882,"marketCap":210510827},{"date":"2024-03-28","current":-7.68685,"twenty":-8.481474,"median":-3.649021,"eighty":-1.672882,"marketCap":229306437},{"date":"2024-04-05","current":-7.641157,"twenty":-8.481927,"median":-3.724744,"eighty":-1.671626,"marketCap":263138534},{"date":"2024-04-12","current":-7.369848,"twenty":-8.481927,"median":-3.751671,"eighty":-1.671626,"marketCap":221788193},{"date":"2024-04-19","current":-5.912533,"twenty":-8.481927,"median":-3.788188,"eighty":-1.671626,"marketCap":177931770},{"date":"2024-04-26","current":-6.328909,"twenty":-8.481474,"median":-3.822843,"eighty":-1.672882,"marketCap":190462177},{"date":"2024-05-03","current":-6.328909,"twenty":-8.481474,"median":-3.858489,"eighty":-1.672882,"marketCap":190462177},{"date":"2024-05-10","current":-7.036747,"twenty":-8.481474,"median":-3.885585,"eighty":-1.672882,"marketCap":211763868},{"date":"2024-05-17","current":-6.819219,"twenty":-8.481474,"median":-3.91687,"eighty":-1.672882,"marketCap":202469439},{"date":"2024-05-24","current":-6.183888,"twenty":-8.481474,"median":-3.940818,"eighty":-1.672882,"marketCap":183605827},{"date":"2024-05-31","current":-5.506202,"twenty":-8.481474,"median":-3.97625,"eighty":-1.672882,"marketCap":163484640},{"date":"2024-06-07","current":-5.379136,"twenty":-8.481474,"median":-3.987714,"eighty":-1.672882,"marketCap":159711918},{"date":"2024-06-14","current":-5.209714,"twenty":-8.481927,"median":-4.011197,"eighty":-1.671626,"marketCap":154681621},{"date":"2024-06-21","current":-4.701449,"twenty":-8.48238,"median":-4.074451,"eighty":-1.676651,"marketCap":139590731},{"date":"2024-06-28","current":-4.828516,"twenty":-8.488979,"median":-4.09574,"eighty":-1.683354,"marketCap":143363454},{"date":"2024-07-05","current":-4.955582,"twenty":-8.488979,"median":-4.104479,"eighty":-1.683354,"marketCap":147136176},{"date":"2024-07-12","current":-5.421491,"twenty":-8.488979,"median":-4.121002,"eighty":-1.683354,"marketCap":160969492},{"date":"2024-07-15","current":-5.548557,"twenty":-8.488979,"median":-4.131804,"eighty":-1.683354,"marketCap":164742214},{"date":"2024-08-02","current":-5.463846,"twenty":-8.711157,"median":-4.172692,"eighty":-1.713285,"marketCap":162227066},{"date":"2024-08-09","current":-5.082648,"twenty":-8.711157,"median":-4.200465,"eighty":-1.738217,"marketCap":150908899},{"date":"2024-08-16","current":-6.21264,"twenty":-8.711157,"median":-4.227479,"eighty":-1.751216,"marketCap":160969492},{"date":"2024-08-23","current":-6.649466,"twenty":-8.711157,"median":-4.246162,"eighty":-1.776296,"marketCap":172287659},{"date":"2024-08-30","current":-6.649466,"twenty":-8.711157,"median":-4.273258,"eighty":-1.817246,"marketCap":172287659},{"date":"2024-09-06","current":-6.60093,"twenty":-8.711157,"median":-4.284474,"eighty":-1.839851,"marketCap":171030085},{"date":"2024-09-13","current":-7.280437,"twenty":-8.711157,"median":-4.324843,"eighty":-1.88874,"marketCap":188636124},{"date":"2024-09-20","current":-7.086292,"twenty":-8.711157,"median":-4.370697,"eighty":-1.913185,"marketCap":183605827},{"date":"2024-09-27","current":-6.746538,"twenty":-8.711157,"median":-4.583477,"eighty":-1.929823,"marketCap":174802808},{"date":"2024-10-04","current":-6.843611,"twenty":-8.711157,"median":-4.627977,"eighty":-1.971852,"marketCap":177317956},{"date":"2024-10-11","current":-6.746538,"twenty":-8.711157,"median":-4.729398,"eighty":-2.044171,"marketCap":174802808},{"date":"2024-10-18","current":-7.037756,"twenty":-8.711157,"median":-4.761476,"eighty":-2.084221,"marketCap":182348253},{"date":"2024-10-25","current":-6.843611,"twenty":-8.711157,"median":-4.780081,"eighty":-2.1198,"marketCap":177317956},{"date":"2024-10-31","current":-6.843611,"twenty":-8.711157,"median":-4.828516,"eighty":-2.160122,"marketCap":177317956},{"date":"2024-11-08","current":-7.280437,"twenty":-8.711157,"median":-4.85329,"eighty":-2.209268,"marketCap":188636124},{"date":"2024-11-15","current":-6.404359,"twenty":-8.711157,"median":-4.870871,"eighty":-2.256127,"marketCap":172347717},{"date":"2024-11-22","current":-5.562911,"twenty":-8.711157,"median":-4.894975,"eighty":-2.281272,"marketCap":149703492},{"date":"2024-11-29","current":-6.077129,"twenty":-8.711157,"median":-4.934835,"eighty":-2.312131,"marketCap":163541630},{"date":"2024-12-06","current":-5.609658,"twenty":-8.711157,"median":-4.985169,"eighty":-2.475809,"marketCap":150961504},{"date":"2024-12-13","current":-5.375922,"twenty":-8.711157,"median":-5.040425,"eighty":-2.60998,"marketCap":144671442},{"date":"2024-12-20","current":-4.581221,"twenty":-8.711157,"median":-5.040558,"eighty":-2.633317,"marketCap":123285228},{"date":"2024-12-27","current":-4.955198,"twenty":-8.711157,"median":-5.040558,"eighty":-2.657728,"marketCap":133349329},{"date":"2025-01-03","current":-4.488194,"twenty":-8.711157,"median":-5.040558,"eighty":-2.670479,"marketCap":120781783},{"date":"2025-01-10","current":-4.322709,"twenty":-8.711157,"median":-5.040558,"eighty":-2.691534,"marketCap":116328419},{"date":"2025-01-17","current":-3.957614,"twenty":-8.711157,"median":-5.040558,"eighty":-2.715746,"marketCap":106503341},{"date":"2025-01-24","current":-4.38909,"twenty":-8.711157,"median":-5.040558,"eighty":-2.756011,"marketCap":118114797},{"date":"2025-01-31","current":-4.045031,"twenty":-8.711157,"median":-5.040558,"eighty":-2.780373,"marketCap":108855825},{"date":"2025-02-07","current":-3.763146,"twenty":-8.711157,"median":-5.040558,"eighty":-2.822548,"marketCap":101270009},{"date":"2025-02-14","current":-3.809893,"twenty":-8.711157,"median":-5.040558,"eighty":-2.846579,"marketCap":102528022},{"date":"2025-02-21","current":-3.926293,"twenty":-8.711157,"median":-5.040558,"eighty":-2.862531,"marketCap":105660473},{"date":"2025-02-28","current":-3.482663,"twenty":-8.711157,"median":-5.040558,"eighty":-2.923981,"marketCap":93721934},{"date":"2025-03-07","current":-3.508374,"twenty":-8.711157,"median":-5.040562,"eighty":-2.950266,"marketCap":94413841},{"date":"2025-03-14","current":-3.20405,"twenty":-8.711157,"median":-5.040562,"eighty":-2.980787,"marketCap":86224179},{"date":"2025-03-21","current":-3.344759,"twenty":-8.711157,"median":-5.040562,"eighty":-3.008758,"marketCap":90010797},{"date":"2025-03-28","current":-3.538197,"twenty":-8.711157,"median":-5.040562,"eighty":-3.027033,"marketCap":90238164},{"date":"2025-04-04","current":-3.254067,"twenty":-8.711157,"median":-5.040562,"eighty":-3.056151,"marketCap":82991727},{"date":"2025-04-11","current":-2.986651,"twenty":-8.711157,"median":-5.040558,"eighty":-3.060228,"marketCap":76171551},{"date":"2025-04-17","current":-3.064141,"twenty":-8.711157,"median":-5.040558,"eighty":-3.067271,"marketCap":78147852},{"date":"2025-04-25","current":-3.710396,"twenty":-8.711157,"median":-5.040562,"eighty":-3.087342,"marketCap":94629944},{"date":"2025-05-02","current":-4.269539,"twenty":-8.711157,"median":-5.040562,"eighty":-3.101923,"marketCap":108890313},{"date":"2025-05-09","current":-4.101391,"twenty":-8.711157,"median":-5.040562,"eighty":-3.137555,"marketCap":104601869},{"date":"2025-05-16","current":-4.832598,"twenty":-8.711157,"median":-5.042039,"eighty":-3.145675,"marketCap":127309955},{"date":"2025-05-23","current":-4.265297,"twenty":-8.711157,"median":-5.042039,"eighty":-3.158264,"marketCap":112364986},{"date":"2025-05-30","current":-3.728887,"twenty":-8.711157,"median":-5.042039,"eighty":-3.172478,"marketCap":98233788},{"date":"2025-06-06","current":-4.215775,"twenty":-8.711157,"median":-5.042039,"eighty":-3.190566,"marketCap":111060369},{"date":"2025-06-13","current":-4.230484,"twenty":-8.711157,"median":-5.042039,"eighty":-3.19945,"marketCap":111447879}],"updateTime":1750136066547}}}